Screening: HPV testing for cervical cancer: The good, the bad, and the ugly

Nature Reviews Clinical Oncology

Volumn 7, Issue 7, 2010, Pages 364-365

  Castle, Philip E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; DNA DETERMINATION; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PRECANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS; ADULT; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADULT; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 77954222473     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.96     Document Type: Short Survey

References (10)

1. Ronco, G. et al. efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 11, 249-257 (2010).
2. Bulkmans, N. W. et al. Human papillomavirus DnA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 370, 1764-1772 (2007).
3. Sankaranarayanan, R. et al. HPv screening for cervical cancer in rural india. N. Engl. J. Med. 360, 1385-1394 (2009).
4. Dillner, J. et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint european cohort study [abstract]. BMJ 337, a1754 (2008).
5. Kitchener, H. C. et al. HPv testing in combination with liquid-based cytology in primary cervical screening (ARTisTiC): a randomised controlled trial. Lancet Oncol. 10, 672-682 (2009).
6. Stoler, M. H. & schiffman, M. interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the AsCUs-LsiL Triage study. JAMA 285, 1500-1505 (2001).
7. Siebers, A. G. et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA 302, 1757-1764 (2009).
8. Meissner, H. I., Tiro, J. A., Yabroff, K. R., Haggstrom, D. A. & Coughlin, S. S. Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med. Care 48, 249-259 (2010).
9. Yabroff, K. R. et al. specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann. Intern. Med. 151, 602-611 (2009).
10. Saraiya, M., Martinez, G., Glaser, K. & Kulasingam, s. Pap testing and sexual activity among young women in the United states. Obstet. Gynecol. 114, 1213-1219 (2009).